Evidence-based child health: SIGN and NICE

Archives of Disease in Childhood: Education and Practice Edition

Volumn 93, Issue 6, 2008, Pages 190-198

  Kelnar, C J H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GONADORELIN DERIVATIVE; GROWTH HORMONE;

CHILD CARE; CHILD HEALTH; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TURNER SYNDROME; UNSPECIFIED SIDE EFFECT;

EID: 57149121514     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Moyer V, Elliott E. Preface. In: Moyer V, Elliott E, Davis R, et al, eds. Evidence based paediatrics and child health. London: BMJ Books, 2000.
2. Lind J. A treatise of the scurvy. In three parts. Containing an inquiry into the nature, causes and cure, of that disease. Together with a critical and chronological view of what has been published on the subject. Edinburgh: Sands, Murray and Cochran for Kincaid and Donaldson, 1753.
3. Banting FG, Best CH, Collip JB, et al. Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 1922;12:141-6.
4. Kirk-Smith MD, Stretch DD. Evidence-based medicine and randomized double-blind clinical trials: a study of flawed implementation. J Eval Pract 2001;7:119-23.
5. Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity. I. Clinical trials. Lancet 2001;357:373-80.
6. Tanner JM. Fetus into man. Boston: Harvard University Press, 1978.
7. Centers for Disease Control (CDC). Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone. MMWR Morb Mortal Wkly Rep 1985;34:359-60, 365-6.
8. Powell-Jackson J, Weller AD, Kennedy P, et al. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985;2:244-6.
9. Gibbs CJ Jr, Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 1985;313:734-8.
10. Brown P, Gajdusek DC, Gibbs CJ Jr, et al. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985;313:728-31.
11. MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity. II. Observational studies. Lancet 2001;357:455-6.
12. Drake AM, Kelnar CJH. The evaluation of growth and the identification of growth hormone deficiency. Arch Dis Child Educ Pract Ed 2006;91:ep61-7.
13. Dattani MT, Pringle PJ, Hindmarsh PC, et al. What is a normal stimulated growth hormone concentration? J Endocrinol 1992;133:447-50.
14. Kelnar CJH. Pride and prejudice: stature in perspective. Acta Paediatri Scand 1990;370(Suppl):5-15.
15. Dawkins R. Gaps in the mind. In: A devil's chaplain: selected essays. London: Weidenfeld and Nicolson, 2003.
16. Asher R. Straight and crooked thinking in medicine. BMJ 1954;2:460-2.
17. Carroll L (Charles Lutwidge Dodgson). Through the looking-glass, and what Alice found there. London: Macmillan & Co, 1872.
18. Wit J-M, Ranke MB, Kelnar CJH, eds. ESPE Classification of Paediatric Endocrine Diagnoses. Hormone Research Special Edition 68(Suppl 2):1-120.
19. Noble D. The music of life: biology beyond genes. Oxford: Oxford University Press, 2006.
20. Sweeney K, Kernick D. Clinical evaluation: constructing a new model for post-normal medicine. J Eval Clin Pract 2002;8:131-8.
21. Field MJ, Lohr KN, eds. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: directions for a new program. Washington DC: National Academy Press, 1990.
22. General Medical Council. Good medical practice. London: GMC, 2006.
23. Martin S, Rice N, Smith PC. The link between healthcare spending and health outcomes: evidence from English programme budgeting data. London: The Health Foundation, 2007.
24. National Health and Medical Research Council (Australia). How to compare the costs and benefits: evaluation of the economic evidence. Handbook series on preparing clinical practice guidelines. Canberra: National Health and Medical Research Council (Australia), 2001.
25. Pagliari C, Grimshaw J, Eccles M. The potential influence of small group processes on guideline development. J Eval Clin Pract 2001;7:165-73.
26. Dixon-Woods M, Agarwal S, Jones D, et al. Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Serv Res Policy 2005;10:45-53.
27. Dixon-Woods M, Fitzpatrick R, Roberts K. Including qualitative research in systematic reviews: opportunities and problems. J Eval Clin Pract 2001;7:125-33.
28. Welsby PD. Evidence-based medicine, guidelines, personality types, relatives and absolutes. J Eval Clin Pract 2002;8:163-6.
29. Georgiou A. Data information and knowledge: the health informatics model and its role in evidence-based medicine. J Eval Clin Pract 2002;8:127-30.
30. Couthard MG. NICE on childhood UTI: nasty processes produce nasty guidelines. BMJ 2007;335:463 [author reply 463-4].
31. Agency for Health Care Policy and Research. Clinical practice guideline no. 1: acute pain management: operative or medical procedures and trauma. Rockville, MD: US Department of Health and Human Services. Agency for Health Care Policy and Research, 1993; AHCPR Publication No 92-0023.
32. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 1991;323:334-6.
33. Kelnar CJH, Stanhope R. Height prognosis in girls with central precocious puberty treated with GnRH analogues. Clin Endocrinol 2002;56:295-6.
34. Stephure DK. Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 2005;90:3360-6.
35. Carel JC. Growth hormone in Turner syndrome: twenty years after, what can we tell our patients? J Endocrinol Metab 2005;90:3793-4.
36. Miles A, Bentley P, Polychronis A, et al. Recent developments in the evidence-based healthcare debate. J Eval Clin Pract 2001;7:85-9.
37. Miles A, Grey JE, Polychronis A, et al. Critical advances in the evaluation and development of clinical care. J Eval Clin Pract 2002;8:87-102.
38. Miles A, Grey JE, Polychronis A, et al. Current thinking in the evidence-based health care debate. J Eval Clin Pract 2003;9:95-109.
39. Miles A, Grey JE, Polychronis A, et al. Developments in the evidence-based health care debate - 2004. J Eval Clin Pract 2004;10:129-42.
40. Miles A, Loughlin M. Continuing the evidence-based health care debate in 2006. The progress and price of EBM. J Eval Clin Pract 2006;12:385-98.
41. Miles A, Loughlin M, Polychronis A. Medicine and evidence: knowledge and action in clinical practice. J Eval Pract 2007;13:481-503.